# Alnylam Pharmaceuticals

**Source:** https://www.startuphub.ai/startups/alnylam-pharmaceuticals
**Profile type:** Startup

> Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.

## About

Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company that develops innovative therapies based on RNA interference (RNAi). By silencing disease-causing genes at the genetic level, the company provides transformative treatments for patients with rare and common genetic, metabolic, and cardiovascular diseases.

## Key facts

- **Slug:** alnylam-pharmaceuticals
- **Website:** https://www.alnylam.com
- **Location:** Cambridge, Massachusetts, United States
- **Founded:** 2002-06-14
- **Operating status:** Active
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/alnylam-pharmaceuticals
  - Twitter: https://x.com/alnylam
  - GitHub: https://github.com/newrelic
  - Facebook: https://facebook.com/alnylampharma

## Frequently asked

### What does Alnylam Pharmaceuticals do?

Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company that develops innovative therapies based on RNA interference (RNAi). By silencing disease-causing genes at the genetic level, the company provides transformative treatments for patients with rare and common genetic, metabolic, and cardiovascular diseases.

### Where is Alnylam Pharmaceuticals headquartered?

Alnylam Pharmaceuticals is headquartered in Cambridge, Massachusetts, United States.

### When was Alnylam Pharmaceuticals founded?

Alnylam Pharmaceuticals was founded in 2002.

### What industry does Alnylam Pharmaceuticals operate in?

Alnylam Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare.

### What is Alnylam Pharmaceuticals's valuation?

StartupHub estimates Alnylam Pharmaceuticals's effective valuation at $31.7B (range $22.8B to $68.5B, 58% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Alnylam Pharmaceuticals",
          "item": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals#webpage",
      "url": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals",
      "name": "Alnylam Pharmaceuticals - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Alnylam Pharmaceuticals. Alnylam Pharmaceuticals is a startup founded in 2002, operating in Biotechnology and Pharmaceuticals. Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases. Headquartered in Cambridge, Massachusetts, United States.",
      "dateModified": "2026-05-01T10:39:55.16296+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals#organization",
      "name": "Alnylam Pharmaceuticals",
      "url": "https://www.alnylam.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1a5c5780-6331-408c-a600-20ea6a1c1e28-square.png",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1a5c5780-6331-408c-a600-20ea6a1c1e28-square.png",
      "description": "This is the official profile of Alnylam Pharmaceuticals. Alnylam Pharmaceuticals is a startup founded in 2002, operating in Biotechnology and Pharmaceuticals. Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases. Headquartered in Cambridge, Massachusetts, United States.",
      "sameAs": [
        "https://www.linkedin.com/company/alnylam-pharmaceuticals",
        "https://x.com/alnylam",
        "https://github.com/newrelic",
        "https://facebook.com/alnylampharma",
        "https://www.startuphub.ai/startups/alnylam-pharmaceuticals"
      ],
      "foundingDate": "2002-06-14",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "Massachusetts",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals#profile-assessment",
      "name": "Alnylam Pharmaceuticals - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/alnylam-pharmaceuticals",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1a5c5780-6331-408c-a600-20ea6a1c1e28-square.png",
      "category": "Biotechnology",
      "description": "This is the official profile of Alnylam Pharmaceuticals. Alnylam Pharmaceuticals is a startup founded in 2002, operating in Biotechnology and Pharmaceuticals. Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases. Headquartered in Cambridge, Massachusetts, United States. Agent Readiness score: 37/100. Full audit: https://www.startuphub.ai/startups/alnylam-pharmaceuticals/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Alnylam Pharmaceuticals"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-01",
        "name": "Alnylam Pharmaceuticals - Profile Score 19/100",
        "reviewBody": "This is the official profile of Alnylam Pharmaceuticals. Alnylam Pharmaceuticals is a startup founded in 2002, operating in Biotechnology and Pharmaceuticals. Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases. Headquartered in Cambridge, Massachusetts, United States. Agent Readiness score: 37/100. Full audit: https://www.startuphub.ai/startups/alnylam-pharmaceuticals/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 19,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```